Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$92.83 -0.58 (-0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Cash & Current Investments (2016 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) reported Cash & Current Investments of $330.9 million for Q2 2026, up 13.7% from $291 million a year earlier but down 2.9% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Cash & Current Investments (2016 - 2026) Analysis & Trends

At the end of FY2025, Rhythm Pharmaceuticals posted Cash & Current Investments of $388.95 million, up 21.3% from FY2024.

  • Cash & Current Investments has a five-year compound annual growth rate of 17.6% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $320.57 million in FY2024 (+16.2%), $275.85 million in FY2023 (-17.2%), $333.29 million in FY2022 (+13.0%) and $294.86 million in FY2021 (+70.6%).
  • Five-year quarterly Cash & Current Investments spans a low of $201.2 million in Q1 2024 and a high of $416.1 million in Q3 2025.
  • Year over year, Cash & Current Investments has now increased in each of the last four quarters, with growth averaging 18.3% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was Q3 2021 (growth of 382.4%); the low point was Q1 2022 (a decline of 40.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $340.63 million (Q1 2026), $388.95 million (Q4 2025) and $416.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Rhythm Pharmaceuticals 6.39 Bn 5.26 Bn 62.32 Mn 330.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 330.90 Mn
Mar 31, 2026 340.63 Mn
Dec 31, 2025 388.95 Mn
Sep 30, 2025 416.10 Mn
Jun 30, 2025 291.00 Mn
Mar 31, 2025 314.49 Mn
Dec 31, 2024 320.57 Mn
Sep 30, 2024 298.39 Mn
Jun 30, 2024 319.13 Mn
Mar 31, 2024 201.20 Mn
Dec 31, 2023 275.85 Mn
Sep 30, 2023 299.26 Mn
Jun 30, 2023 253.60 Mn
Mar 31, 2023 294.58 Mn
Dec 31, 2022 333.29 Mn
Sep 30, 2022 347.80 Mn
Jun 30, 2022 235.60 Mn
Mar 31, 2022 240.96 Mn
Dec 31, 2021 294.86 Mn
Sep 30, 2021 328.35 Mn
API Access

Rhythm Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RYTM&period=max&api_key=YOUR_API_KEY